Jan 6, 2022
Tzvia Bader is the CEO and Co-Founder of TrialJectory which is an Ai-powered tech platform that matches cancer patients with the right clinical trials for their exact diagnosis. TrialJectory also gives pharmaceutical companies and CROs access to patient insights to allow them to effectively design and recruit for clinical trials.
Tzvia explains, "TrialJectory can really be the place where you can easily see all your options, understand all your options, and act upon your options. And by that remove barriers that exist today in patient access to clinical trials and patient access to the most advanced precision offering that exists today for cancer patients."
"I think it's taking some things that have been partially provided, not integrated, and also taking it to the next level of really using smart technology and leveraging it to really personalize it and help and make it relevant and to the patient themselves."
#Cancer #PatientChampion #CancerCare #CancerTreatment #CancerJourney #ClinicalTrials #AI #AIPlatform #DiversityinClinicalTrials